MiR-378a-3p and miR-491-5p as markers of xenon abuse in doping control; [MiR-378a-3p и miR-491-5p как маркеры применения ксеноновых ингаляций в допинг-контроле: пилотное исследование]

Xenon stimulates the synthesis of the hormone erythropoietin, which leads to improved oxygen supply to tissues, increased endurance and can be used by athletes to gain an undue advantage in competitions. The World Anti-Doping Agency (WADA) banned its use. The determination of xenon in biological fluids, in particular, in blood plasma samples, is difficult due to the narrow detection window. Its indirect detection is possible by changing in some blood parameters during a clinical analysis (RET%, HGB, HCT, etc.), however, this analysis is nonspecific and the use of other erythropoiesis-stimulating agents can lead to similar changes. Aims: The aim of the study was to search for long-term microRNA markers, the expression of which is specific and markedly altered by inhaled xenon. Methods: Quantitative real-time PCR was performed on CFX96 Bio-Rad analyser using miRCURY® LNA® miRNA SYBR® Green PCR Kit and panels for studying the expression profiles of mature microRNAs of the hypoxia signaling pathway miRCURY LNA™ miRNA Focus Panel. Results: Based on statistical data analysis, it was found that the expression of hsa-miR-378a-3p and hsa-miR-491-5p in blood plasma increases significantly (more than 70 times) when xenon inhalations are used as an erythropoiesis stimulator. Measurement of hematological parameters before and after inhalation showed no significant changes that could affect endurance or give competitive advantages. Conclusion: The evaluated difference in microRNA expression levels before and after administration of the xenon mixture (Xe/O2) makes hsa-miR-378a-3p and hsa-miR-491-5p potential candidates for the role of long-term markers of xenon abuse. © 2023 National Electronic-Information Consortium (NEICON). All rights reserved.

Авторы
Postnikov P.V. , Ordzhonikidze Z.G. , Khanferyan R.A. , Efimova Y.A. , Pronina I.V.
Издательство
Русский врач
Номер выпуска
4
Язык
Русский
Страницы
54-64
Статус
Опубликовано
Том
13
Год
2023
Организации
  • 1 National Anti-Doping Laboratory (Institute), Lomonosov Moscow State University (NADL MSU), Russian Federation
  • 2 State Autonomous Healthcare Institution “Moscow Centre for research and practice in medical rehabilitation, restorative and sports medicine of Moscow healthcare Department”, Russian Federation
  • 3 Medical Institute of People`s Friendship University of Russia (RUDN), Russian Federation
  • 4 M.V. Lomonosov Institute of Fine Chemical Technologies, MIREA, Russian Technological University, Russian Federation
  • 5 Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology”, Russian Federation
Ключевые слова
antidoping control; erythropoiesis stimulants; microRNA; qPCR-RT; Xenon
Цитировать
Поделиться

Другие записи